According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...

A study by the Stanford Prevention Policy Modeling Lab (PPML) finds that almost 30% of privately insured individuals in the United States, or nearly 40 million people, use at least one of the free ...

A study by the Stanford Prevention Policy Modeling Lab (PPML) finds that almost 30% of privately insured individuals in the ...

Gilead Sciences' leading HIV business might face a slowdown in 2025, even though a potential approval of lenacapavir would be ...

According to the WHO and the latest roadmap, all 3 infections of HIV, syphilis and hepatitis-B, can be transmitted from women to their newborns during pregnancy and childbirth. In addition, HIV can be ...

And in patients with type 2 diabetes at risk for metabolic dysfunction-associated steatotic liver disease, a two-tier ...

A study by the Stanford Prevention Policy Modeling Lab (PPML) finds that almost 30% of privately insured individuals in the United States, or nearly ...

Detailed price information for Coya Therapeutics Inc (COYA-Q) from The Globe and Mail including charting and trades.

On the occasion of World Hemophilia Day, let us reflect on this disorder and examine the current state of treatment for ...

Dynavax Technologies Corporation  ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has filed ...

With early detection and proper care, Sexually transmitted infections (STIs) can be managed. Learn about conditions like ...

Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Highlights Record Financial and Operational Results, Balanced Capital Allocation ...